language_icon
EN
HI

Aarti Pharmalabs Share price

AARTIPHARM

737.4

28.30 (3.99%)
NSE
BSE
Last updated on 30 Apr, 2026 | 11:02 IST
Today's High

746.45

Today's Low

706.55

52 Week Low

585.00

52 Week High

971.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aarti Pharmalabs Chart

Aarti Pharmalabs Share Key Metrics

Volume
2.15 L
Market Cap
6428.54 CR
LTQ@LTP
14@737.40
ATP
735.74
Var Margin
20.88 %
Circuit Range
567.3-850.9
Delivery %
42.51 %
Value
15.82 CR
ASM/GSM
No
Market Lot
1

Summary

Aarti Pharmalabs share price stands at ₹737.4 at 30 Apr, 2026 | 11:02. The stock Aarti Pharmalabs intraday movement has stayed between ₹706.55 and ₹746.45, while on a 52-week basis it has fluctuated from ₹585.00 to ₹971.00.
In terms of trading activity, Aarti Pharmalabs has recorded a volume of 215034 shares. The Aarti Pharmalabs has a market cap of ₹90657751. The stock’s Average Traded Price (ATP) stands at ₹73574, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 14, 73740.
The Aarti Pharmalabs operates within a circuit range of ₹567.3-850.9 – ₹567.3-850.9, with a Value of ₹15.82 CR. The Delivery Percentage for the day is 42.51%. Additionally, Aarti Pharmalabs currently falls under the No framework, and trades with a market lot size of 1.

Aarti Pharmalabs Fundamentals

View More
P/E Ratio

30.33

P/B Ratio

3.1

Div. Yield

0.7

Sector P/E

64.46

Sector P/B

3.52

Sec. Div. Yield

0.57

Aarti Pharmalabs Resistance and Support

Pivot 717.05

Resistance

First Resistance

732.05

Second Resistance

755

Third Resistance

770

Support

First Support

694.1

Second Support

679.1

Third Support

656.15

Aarti Pharmalabs Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

43.08%

Mutual Fund

0.8%

Insurance

5.3%

Foreign Institutional Investors

8.39%

Domestic Institutional Investors

1.32%

Retail

41.11%

Others

0%

Total Promoters
MAR '26
43.08%

Aarti Pharmalabs Corporate Actions

DateAgenda
2026-02-09Quarterly Results & Interim Dividend
2025-11-09Quarterly Results
2025-08-12Quarterly Results
2025-05-10Audited Results & Final Dividend
2025-02-05Quarterly Results

Aarti Pharmalabs News

Aarti Pharmalabs Ltd - 543748 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

Aarti Pharmalabs' promoter, Mr. Mirik Rajendra Gogri, pledged 27.84 lakh shares, representing 3.08% of the company's total share capital. The shares were pledged in favor of Bajaj Financial Securities Limited and 360 One Distribution Services Limited for personal use by the promoter group.
Apr 04 2026 10:04:00

Aarti Pharmalabs Ltd - 543748 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

Renil Rajendra Gogri, a promoter of Aarti Pharmalabs, created a pledge on 1.51 million shares, which is 3.89% of the total share capital. The pledge was made in favor of Aditya Birla Money Limited, Bajaj Financial Securities Limited, and 360 One Distribution Services Limited on March 25, 2026.
Apr 04 2026 10:04:00

Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Aarti Pharmalabs' promoter, Mr. Mirik Rajendra Gogri, pledged 27.84 lakh shares, representing 3.08% of the company's total share capital. The shares were pledged in favor of Bajaj Financial Securities Limited and 360 One Distribution Services Limited for personal use by the promoter group.
Apr 04 2026 10:04:00

Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Renil Rajendra Gogri, a promoter of Aarti Pharmalabs, created a pledge on 1.51 million shares, which is 3.89% of the total share capital. The pledge was made in favor of Aditya Birla Money Limited, Bajaj Financial Securities Limited, and 360 One Distribution Services Limited on March 25, 2026.
Apr 04 2026 10:04:00
Read More

About Aarti Pharmalabs

NSE : 13868  
BSE : 543748  
ISIN : INE0LRU01027  

Aarti Pharmalabs Management

NamePosition
Jeevan MondkarCompany Secretary
Chandrakant V GogriChairman Emeritus
View More

Aarti Pharmalabs FAQs

The Buying Price of Aarti Pharmalabs share is 737.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 30.33. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Aarti Pharmalabs shares is 3.1. Useful to assess the stock's value relative to its book value.

To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 64.46 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Aarti Pharmalabs is 6428.54 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Aarti Pharmalabs share price is 971.00 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Aarti Pharmalabs belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost